Management and long-term outcome of severe acute inflammatory bowel disease

被引:0
|
作者
Lehur, PA [1 ]
GuiberteauCanfrere, V [1 ]
LeBorgne, J [1 ]
机构
[1] HOP HOTEL DIEU,CLIN CHIRURG 2,F-44035 NANTES,FRANCE
来源
SEMAINE DES HOPITAUX | 1997年 / 73卷 / 13-14期
关键词
colitis; ulcerative; crohn disease; colonoscopy; colectomy; drug therapy;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe acute inflammatory bowel disease (SAIBD) poses several challenges to the clinician, who must recognize the severity of the flare, perform an accurate evaluation, and immediately select the most appropriate surgical and/or medical treatment. Once the diagnosis of inflammatory colitis is established, the severity of the flare should be assessed based on clinical and biochemical alterations that indirectly reflect the colonic involvement and, above all, on radiological and endoscopic visualization of the lesions. These investigations ensure identification of complications requiring emergency surgery (colonic perforation, colonic dilatation, severe bleeding). Patients without complications can be treated medically, under close supervision, with corticosteroid therapy (1 mg/kg/d), elimination of oral nutrition, and intravenous fluids and electrolytes. Surgery should be performed if this conservative approach fails; this is currently the most common situation in which surgery is performed in SAIBD. A third situation that requires surgery is occurrence of a relapse at discontinuation of the conservative treatment. Subtotal colectomy with ileostomy and sigmoidostomy is safe in emergency situations, ensures rapid recovery of a satisfactory general condition, supplies data of value for the etiologic diagnosis, and can be followed by any of the currently available techniques for restoring continuity: ileoanal anastomosis with reservoir (ulcerative colitis and indeterminate colitis) or ileorectal anastomosis (Crohn's disease) according to the condition of the rectum and anus, Iu the long-term, 80% of surgically-treated patients recover an unchanged body image and an acceptable to very satisfactory quality of life after an ileorectal or ileoanal anastomosis. Some patients, however, require a permanent ileostomy, particularly those with Crohn's disease diagnosed either during the acute episode or later, sometimes after an ileoanal anastomosis procedure.
引用
收藏
页码:409 / 416
页数:8
相关论文
共 50 条
  • [21] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    Marzo, M.
    Felice, C.
    Mocci, G.
    De Vincentis, F.
    Andrisani, G.
    Pugliese, D.
    Fedeli, P.
    De Vitis, I.
    Papa, A.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S88 - S88
  • [22] LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S12 - S12
  • [23] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, Alessandro
    De pascalis, Barbara
    Roberto, Italia
    Ennas, Sara
    De vincentis, Fabio
    Guglielmo, Simona
    Fedeli, Paolo
    Papa, Alfredo
    De vitis, Italo
    Gasbarrini, Giovanni
    Melina, Domenico
    Fedeli, Giuseppe
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2007, 132 (04) : A183 - A183
  • [24] ANTIMETABOLITES IN INFLAMMATORY BOWEL-DISEASE - LONG-TERM EXPERIENCE
    KORELITZ, BI
    MOUNT SINAI JOURNAL OF MEDICINE, 1990, 57 (05): : 297 - 304
  • [25] Long-Term Impact of Clostridium difficile On Inflammatory Bowel Disease
    Chiplunker, Adeeti
    Ananthakrishnan, Ashwin N.
    Beaulieu, Dawn B.
    Naik, Amar S.
    Zadvornova, Yelena
    Skaros, Susan
    Johnson, Kathryn
    Perera, Lilani P.
    Binion, David G.
    Issa, Mazen
    GASTROENTEROLOGY, 2009, 136 (05) : A199 - A199
  • [26] Inflammatory bowel disease: Short- and long-term treatments
    Bickston, SJ
    Cominelli, F
    DM DISEASE-A-MONTH, 1998, 44 (04): : 144 - 172
  • [27] Long-Term Outcomes of Thalidomide in Refractory Inflammatory Bowel Disease
    Yoon, Jessica
    Gerich, Mark
    Targan, Stephan
    Ippoliti, Andrew
    Vasiliauskas, Eric
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S694 - S695
  • [28] Long-Term Scheduled Therapy with Infliximab in Inflammatory Bowel Disease
    Armuzzi, Alessandro
    De Vincentis, Fabio
    Marzo, Manuela
    Mocci, Giammarco
    Felice, Carla
    Fedeli, Paolo
    De Vitis, Italo
    Papa, Alfredo
    Gasbarrini, Antonio
    Guidi, Luisa
    GASTROENTEROLOGY, 2009, 136 (05) : A663 - A663
  • [29] Long-term scheduled therapy with infliximab in inflammatory bowel disease
    Armuzzi, A.
    De Vincentis, F.
    Marzo, M.
    De Pascalis, B.
    Roberto, I.
    Mocci, G.
    Fiore, F.
    Leso, V.
    Fedeli, P.
    Papa, A.
    De Vitis, I.
    Melina, D.
    Fedeli, G.
    Gasbarrini, A.
    Guidi, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2009, 13 : 84 - 84
  • [30] Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Sarles, Harry E., Jr.
    Whitney, Annette E.
    Kuten, Samantha A.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S643 - S644